Delivery Order SPE2DB22D2218-SPE2DB24FR2WG

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.36 firm fixed-price delivery order is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical products. The contract has an ultimate completion date of June 25, 2024 and was awarded on June 24, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract between...
This federal contract award, valued at $1,318.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a medical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
This federal contract award, valued at $1,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a completion date of November 13, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with a set-aside requirement, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,886.97, is for the supply of 4564878735 ESTROGEN-METHYLTESTOS F.S. TAB 100S. The contract is a firm fixed-price delivery order with a completion date of June 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award is a delivery order valued at $3,046.82 made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos H.S. Tab 100s, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.94 firm fixed-price delivery order is for the supply of "Estrogen-Methyltestos H.S. Tab 100s" and has an ultimate completion date of May 30, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, with a ceiling value of $1,444.13 and an ultimate completion date of April 4, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,257.38, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,128.81, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a pharmaceutical product, with a period of performance through December 10, 2024. The contract is not designated as a set-aside....
This federal contract award, valued at $1,661.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 28, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is part of a larger...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB24FR2WG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,097.83 firm fixed-price delivery order is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical products. The contract has a completion date of July 12, 2024 and was awarded on July 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:10 AM